General MedicationsTOPICALGeneric
PEDIATRIC LTA KIT
LIDOCAINE HYDROCHLORIDE
Standard Dose
2%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview PEDIATRIC LTA KIT is listed in Drugs@FDA under application 088572 (ANDA).
Marketing status: Discontinued Active ingredient LIDOCAINE HYDROCHLORIDE Form and strength SOLUTION;TOPICAL - 2% Sponsor ABBOTT Submission history Latest submission status date: 1984-07-31 00:00:00.
Structured Monograph
Clinical summary
Approval overview PEDIATRIC LTA KIT is listed in Drugs@FDA under application 088572 (ANDA). Marketing status: Discontinued Active ingredient LIDOCAINE HYDROCHLORIDE Form and strength SOLUTION;TOPICAL - 2% Sponsor ABBOTT Submission history Latest submission status date: 1984-07-31 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.